By IPOMarket Editorial Team · Last reviewed: May 26, 2026
Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read the offer document carefully and consult a SEBI-registered investment advisor before investing.
Manipal Health Enterprises Limited — India's largest pan-India multispecialty hospital network by bed capacity — filed its Draft Red Herring Prospectus (DRHP) with SEBI on March 23, 2026, setting the stage for what is poised to be India's biggest healthcare IPO ever. The issue combines a fresh issue of ₹8,000 crore with an offer-for-sale (OFS) of 4.32 crore shares by marquee investors led by Temasek. At a targeted valuation of roughly $12 billion (~₹1,00,000 crore), a successful listing would leapfrog Max Healthcare to make Manipal India's most valuable hospital operator.
This review covers the issue structure, business profile, financials, strengths, risks and a decision framework for prospective investors.
Manipal Health Enterprises IPO — Key Details at a Glance
| Detail | Information |
|---|---|
| Company | Manipal Health Enterprises Limited |
| IPO Status | DRHP Filed (March 23, 2026) |
| Issue Type | Book-Built Issue |
| Structure | Fresh Issue ₹8,000 Cr + OFS of 4.32 crore shares |
| Face Value | ₹2 per share |
| Expected IPO Date | Q3–Q4 2026 (4–6 months after SEBI approval) |
| Listing | NSE and BSE Mainboard (proposed) |
| Lead Managers | Kotak Mahindra Capital, Axis Capital, Goldman Sachs India, Jefferies India, JP Morgan India, UBS Securities India, DBS Bank India |
| Registrar | KFin Technologies |
| Expected Valuation | |
| GMP Today | Check live IPO GMP → |
All numbers are based on DRHP-stage public reporting. Final details (price band, dates, exact issue split) will be confirmed in the RHP. For broader pipeline context, see our open IPOs page and upcoming IPOs.
About Manipal Health Enterprises
Manipal Health Enterprises operates India's largest pan-India multispecialty hospital network by bed capacity, having surpassed Apollo Hospitals in total bed capacity in 2025. Headquartered in Bengaluru, Karnataka, the group traces its roots to 1953, with its first hospital opening in 1991. It is led by CEO & MD Dilip Jose.
The network spans 38 hospitals across India, served by 11,058+ doctors, and treated 7.19 million patients in FY25. Manipal has grown both organically and through one of the most aggressive M&A roll-ups in Indian healthcare:
- Vikram Hospital, Bengaluru (2021) — ₹350 crore
- Columbia Asia (2021) — 11 hospitals, ₹2,100 crore
- AMRI Hospitals (2023)
- Medica Synergie (2024)
- Sahyadri Hospitals (2025)
This acquisition-led strategy is what propelled Manipal past Apollo on bed capacity and built its national footprint across South, West and Eastern India.
Financials
Manipal has delivered strong top-line and profit growth, driven by both acquisitions and improving occupancy and case mix.
| Metric | FY23 | FY25 | H1 FY26 |
|---|---|---|---|
| Revenue | ₹4,839 Cr | ₹8,242 Cr | ₹4,713 Cr |
| PAT | ₹414.2 Cr | ₹1,081.67 Cr | ₹571.8 Cr |
| Operating Income | — | ₹2,126 Cr | — |
Revenue grew roughly 70% between FY23 and FY25, while PAT more than doubled. Annualising H1 FY26 implies a full-year FY26 revenue of ~₹9,426 crore, signalling continued momentum into the listing window.
Use of IPO Proceeds
- ₹5,378 crore — debt repayment (primary use of fresh-issue proceeds)
- Balance — general corporate purposes
The OFS portion lets existing investors monetise part of their holding without diluting the company further.
Selling Shareholders (OFS)
| Shareholder | Stake |
|---|---|
| Temasek Holdings (via Imperius Healthcare Investments) | 51% |
| Manipal Group | 31% |
| TPG Asia | 10% |
| Others (Mubadala, Novo Holdings, CalPERS) | 8% |
Investment Strengths
- India's largest hospital network by beds. Manipal overtook Apollo in total bed capacity in 2025, giving it national scale across 38 hospitals — a structurally hard-to-replicate footprint.
- Strong, consistent financial growth. Revenue up ~70% from FY23 to FY25 and PAT more than doubling demonstrates operating leverage as acquired hospitals ramp toward maturity.
- Marquee institutional backing. Temasek, TPG, Mubadala, Novo Holdings and CalPERS on the cap table bring governance discipline and global healthcare expertise.
- Proven M&A integration engine. Five major acquisitions (Columbia Asia, AMRI, Medica, Sahyadri, Vikram) successfully folded into a single national platform — a repeatable inorganic growth lever.
- Structural healthcare tailwinds. Rising health insurance penetration, an ageing population, growing lifestyle-disease burden and under-bedded Indian healthcare support multi-year demand for organised hospital capacity.
Risks & Concerns
- Heavy debt burden. ₹5,378 crore of fresh-issue proceeds — the bulk of the raise — goes to debt repayment, underscoring a leveraged balance sheet built through acquisitions.
- Revenue geographic concentration. Earnings are concentrated in Karnataka, Maharashtra/Goa and Eastern India; regional regulatory, pricing or demand shocks would hit disproportionately.
- Volume and occupancy dependence. Hospital economics hinge on patient volumes and bed occupancy; a slowdown in elective procedures or occupancy compresses margins quickly given high fixed costs.
- Ramp-up risk on new hospitals. Newly built or recently acquired hospitals take time to reach mature occupancy and margins, which can weigh on blended profitability in the near term.
Manipal Health Enterprises IPO GMP
GMP is not yet available — IPO dates have not been announced. Grey market premium is only quoted once an IPO is officially priced and dated. There is no Manipal Health Enterprises GMP today. Track the live IPO GMP page for currently active IPOs, and watch our 2026 IPO performance tracker for listing-gain context across the year's issues.
Should You Subscribe to Manipal Health Enterprises IPO?
A sensible decision framework as the IPO approaches:
- Wait for the RHP. The price band, exact fresh-vs-OFS split and final audited financials will be disclosed only at RHP stage. Treat pre-RHP commentary as directional.
- Anchor valuation against listed peers. Use [Apollo Hospitals], Max Healthcare (market cap ~₹94,053 crore), Fortis Healthcare and Global Health (Medanta) as multiple anchors. A ~₹1,00,000 crore valuation would make Manipal the most valuable listed hospital operator — that premium must be justified by superior growth and margins, not scale alone.
- Weigh the debt-repayment use. A raise dominated by debt repayment de-risks the balance sheet but adds less directly to growth capacity than a capex-led raise.
- Treat as a multi-year healthcare play. The structural under-bedding of Indian healthcare plays out over years. Size any allocation as a long-term position, not a listing-day flip.
- Pick the right broker. See our guide on the best broker for IPO applications and learn the basics in our introduction to IPO investing.
How to Track Manipal Health Enterprises IPO Updates
We track every major SEBI-filed IPO on our IPO pipeline and upcoming IPOs in 2026 pages. Subscribe to our IPO alerts to be notified the moment Manipal Health opens for subscription.
Frequently Asked Questions
When will the Manipal Health Enterprises IPO open? The DRHP was filed with SEBI on March 23, 2026. Issuers typically launch 4–6 months after SEBI approval, placing the likely window in Q3–Q4 2026. The exact date will be confirmed in the RHP.
What is the Manipal Health Enterprises IPO size? A fresh issue of ₹8,000 crore plus an OFS of 4.32 crore shares. At the targeted ~$12 billion valuation, it would be India's biggest healthcare IPO ever.
Who are the selling shareholders? Temasek (51%, via Imperius Healthcare Investments) leads the OFS, alongside the Manipal Group (31%), TPG Asia (10%) and others including Mubadala, Novo Holdings and CalPERS (8%).
How did Manipal become India's largest hospital network? Through aggressive M&A — acquiring Columbia Asia (2021), AMRI Hospitals (2023), Medica Synergie (2024), Sahyadri Hospitals (2025) and Vikram Hospital Bengaluru (2021) — Manipal surpassed Apollo Hospitals in total bed capacity in 2025, operating 38 hospitals nationwide.
What is the Manipal Health Enterprises IPO GMP today? GMP is not yet available because IPO dates have not been announced. Track the live IPO GMP page for active IPOs.
Last reviewed: May 26, 2026 by IPOMarket Editorial Team. We update this page when the RHP is filed or the open date is announced.